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ABSTRACT 
White adipose tissue samples from obese and lean patients were 
used for the estimation ofinsulin protease and insulin:glutathione 
transhydrogenase using 1251-labeled insulin. There was no activity 
detected in the absence of reduced glutathione, which indicates 
that insulin is cleaved in human adipose "tissue through reduction 
of the disulfide bridge between the chains. O bese patients showed 
higher transhydrogenase activity (per U tissue protein wt, per U 
tissue wt, and in the total adipose tissue mass) than the lean group. 
There is a significant correlation between the activity per U tissue 
OBESITY is often characterized by hyperinsulinemia, which has a direct bearing on the increased lipid 
accrual in obese individuals, insulin resistance, and late-
onset diabetes (1). Because hepatic disposal of insulin is 
decreased in obesity (2), we attempted to investiga te whether 
this trend was also observed in adipose tissue, as its large 
mass in the obese may influence peripheral insulin degra-
dation to a greater extent than in individuals with normal fat 
depots. 
The half-life of circulating insulin is short, in the range of 
minutes, although its functional tumover may be somewhat 
longer in normal weight humans, beca use it is rapidly taken 
up and inactivated by liver (3, 4), adipose tissue (5), and 
muscle (5, 6). Insulin may be inactivated through intern_al-
ization after interacting with its receptor (7), but most of it is 
cleaved by specific systems through a selective proteolytic 
pathway (4) or by means of the more commonly accepted 
reduction of the disulfide bridge between the a- and J3-chains 
(3, 5). This reaction is catalyzed by insulin:glutathione tran-
shydrogenase (EC 1.8.4.2) (3, 5), with glutathione providing 
the reducing power. · 
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wt, and protein and total activity in the whole adipose tissue with 
respect to body mass index, with a higher activity in obese patients. 
The potential ofinsulin cleavage by adipose tissue in obese patients 
was a mean 5.6-fold higher than that in controla. The coexistence 
of high insulinemia and high cleavage capability implies that in-
sulin secretion and turnover are increased in the o bese. Thus, white 
adipose tissue may be crucial in the control of energy availability 
through modulation ofinsulin cleavage. (J Clin Endrocrinol Metab 
80:693-695, 1995) 
Materials and Methods 
Samples of se abdominal white adipose tissue were obtained from 
patients undergoing laparotomy because of hernia (n = S) or chole-
cystectomy (n = 3), control group; five men and three women; body 
mass index (BMI), <27 kg/m2; or obese patients (BMI, >30 kg/m2) 
subjected to laparotomy ~cause of cholecystectomy (n = 1) or ver-
tical-banded gastroplasty (n = 9; seven women and three men). None 
of the women included in the experiment had reached menopause; 
patients receiving medication were not used in the study. Informed 
consent of the patients and of the Clinical Assays Committee was 
obtained prior to the undertaking of the experiments. The parameters 
defining the two groups of patients studied are presented in Table l . 
Blood was extracted in the morning after an ovemight fast; the 
·samples were used for the measurement of glycemia (¡:!) and insu-
linemia (through radioimmunoanalysis; Diagnostic Products Corp., 
Los Angeles, CA). Pieces of adipose tissue ( -2 g) were dissected from 
the abdominal se fat masses near the surgical wound; they were 
immediately frozen in liquid nitro gen after extraction and kept under 
liquid nitrogen or in deep freeze ( -80 C) until processed. Aliquots of 
about 0.5 g tissue were weighed and homogenized with a Polytron 
tissue disrupter (Kinematica, Luzern, Switzerland) in 10 vol chilled 
50 mmol/L phosphate buffer, pH 7.5, containing 250 mmol/L su-
crose. The homogenates were centrifuged for 10 min at 5000 X g, and 
the supernatant layer of fat and the pellet were discarded; the clear 
homogenate was used for the estimation of insulin:glutathione tran-
shydrogenase, using 125!-labeled insulin (Amersham, UK) with the 
method of Thomas and Varandani (9). A set of determinations was 
carried out by omitting the reduced glutathione, as this experimental 
set-up has been used to measure insulin protease (10). Protein in 
homogenates was estimated with the Lowry method (11). 
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The degree of mterrelationship between data was estimated 
by establishing the linear correlation coefficient for paired parame-
ters. Comparison between groups was performed with Student's 
t test. 


